KRAS expression was significantly higher in Cluster2 than in Cluster1 (P < 0.001, Fig. 3G) and in pancreatic cancer samples than in normal samples (P < 0.001, Fig. 3H). This evidence concerns the gene KRAS and familial pancreatic carcinoma.